Robert D. Budens

Array ( [id] => 3920632 [patent_doc_number] => 05914109 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-22 [patent_title] => 'Heterohybridomas producing human monoclonal antibodies to HIV-1' [patent_app_type] => 1 [patent_app_number] => 8/345321 [patent_app_country] => US [patent_app_date] => 1994-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 20 [patent_no_of_words] => 19739 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/914/05914109.pdf [firstpage_image] =>[orig_patent_app_number] => 345321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3663395 [patent_doc_number] => 05656732 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-12 [patent_title] => 'Polypeptides of feline T-cell lymphotrophic lentivirus' [patent_app_type] => 1 [patent_app_number] => 8/306539 [patent_app_country] => US [patent_app_date] => 1994-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 6973 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/656/05656732.pdf [firstpage_image] =>[orig_patent_app_number] => 306539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3627394 [patent_doc_number] => 05621076 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-15 [patent_title] => 'Poultry Mycoplasma antigens and recombinant vectors containing the gene as well as diagnostics and vaccines utilizing the same' [patent_app_type] => 1 [patent_app_number] => 8/299662 [patent_app_country] => US [patent_app_date] => 1994-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 8571 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/621/05621076.pdf [firstpage_image] =>[orig_patent_app_number] => 299662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3586104 [patent_doc_number] => 05496554 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-03-05 [patent_title] => 'Purified mite allergen' [patent_app_type] => 1 [patent_app_number] => 8/283905 [patent_app_country] => US [patent_app_date] => 1994-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 6403 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/496/05496554.pdf [firstpage_image] =>[orig_patent_app_number] => 283905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3759272 [patent_doc_number] => 05851828 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-22 [patent_title] => 'Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells' [patent_app_type] => 1 [patent_app_number] => 8/284391 [patent_app_country] => US [patent_app_date] => 1994-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 56 [patent_no_of_words] => 22676 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/851/05851828.pdf [firstpage_image] =>[orig_patent_app_number] => 284391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3594027 [patent_doc_number] => 05521289 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-05-28 [patent_title] => 'Small organometallic probes' [patent_app_type] => 1 [patent_app_number] => 8/282929 [patent_app_country] => US [patent_app_date] => 1994-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12922 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/521/05521289.pdf [firstpage_image] =>[orig_patent_app_number] => 282929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3985787 [patent_doc_number] => 05891436 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-06 [patent_title] => 'Primary biliary cirrhosis autoantigen and method of use' [patent_app_type] => 1 [patent_app_number] => 8/279818 [patent_app_country] => US [patent_app_date] => 1994-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 6303 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/891/05891436.pdf [firstpage_image] =>[orig_patent_app_number] => 279818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3506732 [patent_doc_number] => 05562904 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-08 [patent_title] => 'Retroviral transduction of cells using soluble complement inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/278550 [patent_app_country] => US [patent_app_date] => 1994-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11764 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/562/05562904.pdf [firstpage_image] =>[orig_patent_app_number] => 278550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3727676 [patent_doc_number] => 05652138 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-29 [patent_title] => 'Human neutralizing monoclonal antibodies to human immunodeficiency virus' [patent_app_type] => 1 [patent_app_number] => 8/276852 [patent_app_country] => US [patent_app_date] => 1994-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 60 [patent_no_of_words] => 61550 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/652/05652138.pdf [firstpage_image] =>[orig_patent_app_number] => 276852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3685329 [patent_doc_number] => 05695927 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-09 [patent_title] => 'Monoclonal antibodies specific for HIV and the hybridomas for production thereof' [patent_app_type] => 1 [patent_app_number] => 8/270214 [patent_app_country] => US [patent_app_date] => 1994-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 24 [patent_no_of_words] => 12268 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/695/05695927.pdf [firstpage_image] =>[orig_patent_app_number] => 270214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3617738 [patent_doc_number] => 05593677 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-14 [patent_title] => 'Method for prevention of graft versus host disease' [patent_app_type] => 1 [patent_app_number] => 8/249651 [patent_app_country] => US [patent_app_date] => 1994-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1549 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/593/05593677.pdf [firstpage_image] =>[orig_patent_app_number] => 249651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3696878 [patent_doc_number] => 05645835 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-08 [patent_title] => 'Therapeutic antibody based fusion proteins' [patent_app_type] => 1 [patent_app_number] => 8/247437 [patent_app_country] => US [patent_app_date] => 1994-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 6181 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/645/05645835.pdf [firstpage_image] =>[orig_patent_app_number] => 247437 [rel_patent_id] =>[rel_patent_doc_number] =>)